Cargando…

The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages

Müllerian inhibiting substance, also called anti-Müllerian hormone (AMH), inhibits proliferation and induces apoptosis of AMH type II receptor-positive tumor cells, such as human ovarian cancers (OCs). On this basis, a humanized glyco-engineered monoclonal antibody (3C23K) has been developed. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bougherara, Houcine, Némati, Fariba, Nicolas, André, Massonnet, Gérald, Pugnière, Martine, Ngô, Charlotte, Le Frère-Belda, Marie-Aude, Leary, Alexandra, Alexandre, Jérôme, Meseure, Didier, Barret, Jean-Marc, Navarro-Teulon, Isabelle, Pèlegrin, André, Roman-Roman, Sergio, Prost, Jean-François, Donnadieu, Emmanuel, Decaudin, Didier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725143/ https://www.ncbi.nlm.nih.gov/pubmed/29245952 http://dx.doi.org/10.18632/oncotarget.21556

Ejemplares similares

The Expression of Anti-Müllerian Hormone Type II Receptor (AMHRII) in Non-Gynecological Solid Tumors Offers Potential for Broad Therapeutic Intervention in Cancer
por: Barret, Jean-Marc, et al.
Publicado: (2021)

Real-Time Imaging of Resident T Cells in Human Lung and Ovarian Carcinomas Reveals How Different Tumor Microenvironments Control T Lymphocyte Migration
por: Bougherara, Houcine, et al.
Publicado: (2015)

Influence of stromal elements on resident T cell migration in human and murine tumors analyzed by real-time imaging
por: Peranzoni, Elisa, et al.
Publicado: (2015)

Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation
por: Prat, Mélissa, et al.
Publicado: (2021)

Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice
por: Coelho, M, et al.
Publicado: (2004)

The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells
por: Estupina, Pauline, et al.
Publicado: (2017)

Ex Vivo Imaging of Resident CD8 T Lymphocytes in Human Lung Tumor Slices Using Confocal Microscopy
por: Peranzoni, Elisa, et al.
Publicado: (2017)

Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice
por: Ladjemi, Maha Z, et al.
Publicado: (2011)

Comparison between Internalizing Anti-HER2 mAbs and Non-Internalizing Anti-CEA mAbs in Alpha-Radioimmunotherapy of Small Volume Peritoneal Carcinomatosis Using (2) (1) (2)Pb
por: Boudousq, Vincent, et al.
Publicado: (2013)

Spontaneous mouse lymphoma in patient-derived tumor xenografts: The importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials
por: Chateau-Joubert, Sophie, et al.
Publicado: (2021)

Assessment of FSHR, AMH, and AMHRII variants in women with polycystic ovary syndrome
por: Czeczuga-Semeniuk, Ewa, et al.
Publicado: (2014)

Predictive Gene Signature of Response to the Anti-TweakR mAb PDL192 in Patient-Derived Breast Cancer Xenografts
por: de Plater, Ludmilla, et al.
Publicado: (2014)

The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma
por: Amirouchene-Angelozzi, Nabil, et al.
Publicado: (2016)

DNA methylation of AMHRII and INSR gene is associated with the pathogenesis of Polycystic Ovary Syndrome (PCOS)
por: Zhong, Xingming, et al.
Publicado: (2021)

Combinations of targeted therapies in human cancers
por: Decaudin, Didier, et al.
Publicado: (2016)

Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds
por: Stimmer, Lev, et al.
Publicado: (2014)

Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9(+) tumors
por: Santamaria, Silvia, et al.
Publicado: (2022)

ITCH-dependent proteasomal degradation of c-FLIP induced by the anti-HER3 antibody 9F7-F11 promotes DR5/caspase 8-mediated apoptosis of tumor cells
por: Le Clorennec, Christophe, et al.
Publicado: (2019)

Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers
por: Garambois, Véronique, et al.
Publicado: (2004)

Peptides in Receptor-Mediated Radiotherapy: From Design to the Clinical Application in Cancers
por: Lozza, Catherine, et al.
Publicado: (2013)

Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
por: Sola, Caroline, et al.
Publicado: (2013)

Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells
por: Passariello, Margherita, et al.
Publicado: (2020)

The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting
por: Li, Yang, et al.
Publicado: (2021)

PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer
por: Suresh, Samyuktha, et al.
Publicado: (2022)

Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action
por: Jouffre, Baptiste, et al.
Publicado: (2023)

Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells
por: Chauvin, Maëva, et al.
Publicado: (2021)

AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells
por: Zajac, Olivier, et al.
Publicado: (2020)

PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance
por: Montaudon, Elodie, et al.
Publicado: (2020)

The in vivo Anti‐tumor Effect of Human Recombinant Interleukin‐6
por: Kitahara, Misa, et al.
Publicado: (1990)

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models
por: He, Li-Zhen, et al.
Publicado: (2013)

Near‐infrared fluorescence‐labeled anti‐PD‐L1‐mAb for tumor imaging in human colorectal cancer xenografted mice
por: Zhang, Mingyu, et al.
Publicado: (2019)

Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings
por: Bieche, Ivan, et al.
Publicado: (2014)

NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor
por: Zhang, Meng, et al.
Publicado: (2023)

Treatment of Marmoset Intracerebral Hemorrhage with Humanized Anti-HMGB1 mAb
por: Wang, Dengli, et al.
Publicado: (2022)

Imaging with Synthetic Aperture Radar
por: Massonnet, Didier, et al.
Publicado: (2008)

Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells
por: Hara, Yuta, et al.
Publicado: (2019)

Anti-Tumor Effects of Atractylenolide-I on Human Ovarian Cancer Cells
por: Long, Fangyi, et al.
Publicado: (2017)

Anti‐tumor Efficacy of Paclitaxel against Human Lung Cancer Xenografts
por: Yamori, Takao, et al.
Publicado: (1997)

Anti-Tumor Activity of Atractylenolide I in Human Colon Adenocarcinoma In Vitro
por: Chan, Ka Woon Karen, et al.
Publicado: (2020)

Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells
por: Pabona, John Mark P, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_347o5dem9tetiubtab2iukb86u